194 related articles for article (PubMed ID: 18374862)
1. [Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].
Firmin D; Karam A; Guillerm G; Roguedas AM; Berthou C; Misery L
Ann Dermatol Venereol; 2008 Mar; 135(3):234-6. PubMed ID: 18374862
[No Abstract] [Full Text] [Related]
2. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
Elad S; Or R; Resnick I; Shapira MY
Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus in severe chronic graft-versus-host disease.
Heinemann C; Kaatz M; Schreiber G; Elsner P; Norgauer J
Acta Derm Venereol; 2005; 85(4):370-1. PubMed ID: 16191870
[No Abstract] [Full Text] [Related]
4. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
5. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
[TBL] [Abstract][Full Text] [Related]
6. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease.
Prot-Labarthe S; Therrien R; Champagne MA; Duval M; Joubert C
Bone Marrow Transplant; 2007 Aug; 40(3):295-6. PubMed ID: 17549052
[No Abstract] [Full Text] [Related]
7. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
[No Abstract] [Full Text] [Related]
8. Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation.
Platz KP; Mueller AR; Langrehr JM; Neuhaus P; Schraut WH
Transplant Proc; 1996 Oct; 28(5):2523-4. PubMed ID: 8907933
[No Abstract] [Full Text] [Related]
9. [Graft versus host disease following liver transplantation. Favorable outcome after treatment with tacrolimus].
Dumortier J; Souraty P; Bernard P; Scoazec JY; Berger F; Euvrard S; Boillot O
Gastroenterol Clin Biol; 2003 May; 27(5):561-2. PubMed ID: 12843926
[No Abstract] [Full Text] [Related]
10. Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD.
Tam PM; Young AL; Cheng LL; Lam PT
Bone Marrow Transplant; 2010 May; 45(5):957-8. PubMed ID: 19802037
[No Abstract] [Full Text] [Related]
11. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease.
Jung JW; Lee YJ; Yoon SC; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2015 Mar; 159(3):519-27.e1. PubMed ID: 25498356
[TBL] [Abstract][Full Text] [Related]
12. Oral graft-versus-host disease: successful therapy with extracorporeal photopheresis and topical tacrolimus.
Schlaak M; Treudler R; Colsman A; Al-Ali H; Simon JC
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):112-3. PubMed ID: 18181987
[No Abstract] [Full Text] [Related]
13. Topical immunosuppression in skin grafting with FK 506 ointment.
Yuzawa K; Taniguchi H; Seino K; Otsuka M; Fukao K
Transplant Proc; 1996 Jun; 28(3):1387-9. PubMed ID: 8658707
[No Abstract] [Full Text] [Related]
14. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients.
Pirenne J; Moon C; Gruessner A; Benedetti E; Nakhleh RE; Uckun F; Gruessner RW
Transplant Proc; 1996 Apr; 28(2):941-2. PubMed ID: 8623472
[No Abstract] [Full Text] [Related]
15. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients.
Choi CJ; Nghiem P
Arch Dermatol; 2001 Sep; 137(9):1202-6. PubMed ID: 11559218
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of vitiligo with 0.1% tacrolimus ointment.
Travis LB; Weinberg JM; Silverberg NB
Arch Dermatol; 2003 May; 139(5):571-4; discussion 573. PubMed ID: 12756092
[No Abstract] [Full Text] [Related]
17. Chronic graft-versus-host disease.
Galbizo E; Williams LA
Oncol Nurs Forum; 2006 Sep; 33(5):881-3. PubMed ID: 16986223
[No Abstract] [Full Text] [Related]
18. Angiolymphoid hyperplasia with eosinophilia successfully treated with tacrolimus ointment.
Wang S; Li W
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):237. PubMed ID: 19686258
[No Abstract] [Full Text] [Related]
19. Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.
Elefante A; Muindi J; West K; Dunford L; Abel S; Paplham P; Brown K; Hahn T; Padmanabhan S; Battiwalla M; McCarthy PL
Bone Marrow Transplant; 2006 Apr; 37(8):781-4. PubMed ID: 16518428
[TBL] [Abstract][Full Text] [Related]
20. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.
Kontos AP; Kerr HA; Fivenson DP; Remishofsky C; Jacobsen G
Int J Dermatol; 2006 Nov; 45(11):1383-5. PubMed ID: 17076739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
